{"id":"W4293555019","doi":"10.3332/ecancer.2022.ed124","title":"CDK 4/6 inhibitors for adjuvant therapy in early breast cancer—Do we have a clear winner?","year":2022,"lang":"en","type":"editorial","venue":"ecancermedicalscience","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"Government of Ontario","keywords":"Palbociclib; Medicine; Adjuvant; Breast cancer; Oncology; Cyclin-dependent kinase; Internal medicine; Cancer; Adjuvant therapy; Clinical trial; Pharmacology; Metastatic breast cancer; Cell cycle","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006952459,0.002596759,0.002130118,0.001837866,0.001741433,0.004384086,0.002897257,0.01147857,0.007270018],"category_scores_gemma":[0.0139789,0.0007222759,0.001899136,0.0008756892,0.00192089,0.004831932,0.0009239312,0.02134601,0.007005756],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002089059,"about_ca_system_score_gemma":0.00210686,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009584863,"about_ca_topic_score_gemma":0.002435728,"domain_scores_codex":[0.9975115,0.0004222659,0.0003559896,0.0002548442,0.00126887,0.0001864782],"domain_scores_gemma":[0.9905874,0.004281525,0.0004961129,0.0002131953,0.002758138,0.001663679],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008469032,0.00002573715,0.00003970298,0.0003970673,0.00002444733,0.0001531825,0.00001899629,0.00003364109,0.000108425,0.0006039105,0.9787751,0.01973502],"study_design_scores_gemma":[0.0001221063,0.00009368134,0.0002604447,0.0005595769,0.00006283221,0.000420512,0.00004401967,0.0001232726,0.0001511088,0.001135029,0.9970085,0.00001907733],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.00009786901,0.02625614,0.0001863561,0.06655202,0.9047315,0.00002680432,0.00003913262,0.00007980588,0.002030377],"genre_scores_gemma":[0.0006361846,0.02031543,0.0001726639,0.05038877,0.9222452,0.00001879137,0.00002805603,0.00003029818,0.006164475],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.01147857,"threshold_uncertainty_score":0.03676862,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01290050894898051,"score_gpt":0.3166935721001164,"score_spread":0.3037930631511359,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}